GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases.
Mentions in press and media 4
| Date | Title | Description |
| 26.12.2024 | GEMMABio: A New Dawn in Gene Therapy with $34 Million Seed Funding | In the bustling world of biotechnology, a new player has emerged. GEMMABio, a Philadelphia-based therapeutics company, has secured $34 million in seed funding. This is not just a financial boost; it’s a lifeline for innovation. Founded by D... |
| 25.12.2024 | GEMMABio: $34 Million (Seed) Raised For Advancing Gene Therapy Advancements | GEMMA Biotherapeutics – a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson – announced the completion of a $34 million seed funding round to accelerate its groundbreaking gene therapy initiatives. The $34 million seed... |
| 24.12.2024 | GEMMABio Raises $34M in Seed Funding | Gemma Biotherapeutics, a Philadelphia, PA-based therapeutics company, closed a $34m seed funding. The round was co-led by Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital, with additional backing from Savanne Li... |
| - | GEMMABio | “GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases.” |